Division of Microbiology, Immunology and Glycobiology - MIG
81 – 90 of 776
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation
- Contribution to journal › Article
-
Mark
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease
- Contribution to journal › Article
-
Mark
Immunomodulation therapy offers new molecular strategies to treat UTI
- Contribution to journal › Scientific review
-
Mark
Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors
- Contribution to journal › Article
-
Mark
Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
- Contribution to journal › Article
-
Mark
Editorial : Methods and applications in inflammation pharmacology
- Contribution to journal › Debate/Note/Editorial
-
Mark
Combined genetic deficiencies of the classical complement pathway are strongly associated with both systemic lupus erythematosus and primary Sjögren's syndrome
- Contribution to journal › Article
-
Mark
Engineering the Ligand Specificity of the Human Galectin-1 by Incorporation of Tryptophan Analogues
- Contribution to journal › Article
-
Mark
NFκB1 Dichotomously Regulates Pro-Inflammatory and Antiviral Responses in Asthma
- Contribution to journal › Article
-
Mark
Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia
- Contribution to journal › Article
